News & Events
Sengenics Corporation Announces New Collaboration to Advance Cancer Treatment
Sengenics Corporation Exhibits at Autoimmunity 2024
Sengenics Corporation Announces Key Distributor in China
Sengenics Corporation Launches i-Ome Discovery™ to Advance Immune Biomarker Discovery and Development
Webinar: Building Bioinformatics
Sengenics Corporation Announces New French Distributor
Sengenics Spotlights Research from NYU on Predicting Immune-related Adverse Events (irAEs) at ASCO Annual Meeting
Sengenics Corporation Announces Fredrik Sundberg as New Vice President of Market and Business Development
Webinar: B Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC
"*" indicates required fields
By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy. I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.
Δ
"*" Indicates required fields By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy. I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.
